<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">genort</journal-id><journal-title-group><journal-title xml:lang="ru">Гений ортопедии</journal-title><trans-title-group xml:lang="en"><trans-title>Genij Ortopedii</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1028-4427</issn><issn pub-type="epub">2542-131X</issn><publisher><publisher-name>ЦЕНТР ИЛИЗАРОВА</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18019/1028-4427-2019-25-3-413-423</article-id><article-id custom-type="elpub" pub-id-type="custom">genort-2476</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Обзор литературы</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Literature review</subject></subj-group></article-categories><title-group><article-title>Особенности патогенетической терапии остеоартроза крупных суставов в клинике спортивной медицины</article-title><trans-title-group xml:lang="en"><trans-title>Pathogenetic treatment of large joint osteoarthritis at the clinic for sports medicine</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Черкасова</surname><given-names>В.Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Cherkasova</surname><given-names>V.G.</given-names></name></name-alternatives><email xlink:type="simple">sergey89.m@mail.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Муравьев</surname><given-names>С.В.</given-names></name><name name-style="western" xml:lang="en"><surname>Murav'yev</surname><given-names>S.V.</given-names></name></name-alternatives><email xlink:type="simple">sergey89.m@mail.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чайников</surname><given-names>П.Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Chaynikov</surname><given-names>P.N.</given-names></name></name-alternatives><email xlink:type="simple">sergey89.m@mail.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кулеш</surname><given-names>А.М.</given-names></name><name name-style="western" xml:lang="en"><surname>Kulesh</surname><given-names>A.M.</given-names></name></name-alternatives><email xlink:type="simple">sergey89.m@mail.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вецлер</surname><given-names>М.В.</given-names></name><name name-style="western" xml:lang="en"><surname>Wetzler</surname><given-names>M.V.</given-names></name></name-alternatives><email xlink:type="simple">sergey89.m@mail.ru</email></contrib></contrib-group><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>28</day><month>09</month><year>2019</year></pub-date><volume>25</volume><issue>3</issue><issue-title>№ 3 (2019)</issue-title><fpage>413</fpage><lpage>423</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Черкасова В., Муравьев С., Чайников П., Кулеш А., Вецлер М., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Черкасова В., Муравьев С., Чайников П., Кулеш А., Вецлер М.</copyright-holder><copyright-holder xml:lang="en">Cherkasova V., Murav'yev S., Chaynikov P., Kulesh A., Wetzler M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ilizarov-journal.com/jour/article/view/2476">https://www.ilizarov-journal.com/jour/article/view/2476</self-uri><abstract><p>В работе обсуждаются вопросы этиологии, патогенеза, патоморфологии и патофизиологии остеоартроза крупных суставов с позиций доказательной медицины. Детально описаны процессы, происходящие в тканях суставов при развитии патологического процесса на различных этапах, подробно освещены особенности диагностики и лечения в условиях спортивной медицины. Дана характеристика медикаментозных препаратов, используемых для лечения остеоартроза, с описанием положительного эффекта и негативного влияния на отдельные органы и системы. Проведен всесторонний анализ эффективности препарата Алфлутоп как в плане безопасности, так и в плане влияния на развитие патологического процесса. Показано, что Алфлутоп является препаратом выбора при лечении деструктивных поражений суставов. </p></abstract><trans-abstract xml:lang="en"><p>The paper discusses the etiology, pathogenesis, pathomorphology and pathophysiology of osteoarthritis of large joints from the perspective of evidencebased medicine. The processes occurring in the tissues of the joints during the development of the pathological process at various stages are described in detail; the features of diagnosis and treatment in sports medicine are described in detail. The characteristic of drugs used to treat osteoarthritis is described, with a description of the positive effect and negative effect on particular organs and systems. A preparation Alflutop was comprehensively analysed regarding its effectiveness in terms of safety and impact on the development of the pathological process. It was shown that Alflutop is a drug of choice in the treatment of joint destruction.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
